Precose

This medication is indicated to support blood sugar control and formulated to target post-prandial hyperglycaemia in type 2 diabetes mellitus.

Strengths: 25 · 50mg

Medicine details

Alternative names

Glucobay

Therapeutic class

Alpha-glucosidase inhibitor

Pharmacological class

Alpha-glucosidase inhibitor

Minor side effects

flatulence; diarrhoea; abdominal ache

Moderate side effects

elevated liver enzymes

Dosage forms

Tablet

Administration route

Oral use

Prescription status

POM

Manufacturer

Bayer

Onset Time

within meal

Duration

4–6 hours

Storage instructions

Store in a cool, dry place away from moisture.

Drug interactions

neomycin; colestyramine; digoxin

Age restrictions

Not recommended for children.

Pregnancy and breastfeeding

Pregnancy: Should not be used. Breastfeeding: Should not be used.

Contraindications

hypersensitivity to acarbose; chronic intestinal diseases; severe renal impairment; inflammatory bowel disease

Precautions and warnings

take with the first bite of each meal; monitor blood glucose regularly; may cause abdominal discomfort

Serious side effects

jaundice — requires immediate medical attention; ileus — requires immediate medical attention

Patient summary

This medication is indicated to support blood sugar control and formulated to target post-prandial hyperglycaemia in type 2 diabetes mellitus.

Mechanism of action

Acarbose acts within the gastrointestinal tract to inhibit alpha-glucosidase enzymes. This slows the breakdown of complex carbohydrates into glucose, resulting in a delayed, and often reduced, increase in blood glucose concentrations following a meal.

Precose

This medication is indicated to support blood sugar control and formulated to target post-prandial hyperglycaemia in type 2 diabetes mellitus.

Editorial Notes

  • Active ingredient(s): Acarbose
  • Listed indication(s): Type 2 Diabetes Mellitus

Usually available as

  • 180 tablets - 25 mg639-25-mg-1352
  • 90 tablets - 50 mg639-50-mg-1356